Angiotensin II Promotes Smooth Muscle Cell Proliferation and Migration through Release of Heparin-binding Epidermal Growth Factor and Activation of EGF-Receptor Pathway |
Yang, Xiaoping
(Center for Cardiovascular Research and Alternative Medicine, University of Wyoming)
Zhu, Mei J. (Department of Animal Science, University of Wyoming) Sreejayan, N. (Center for Cardiovascular Research and Alternative Medicine, University of Wyoming) Ren, J. (Center for Cardiovascular Research and Alternative Medicine, University of Wyoming) Du, Min (Center for Cardiovascular Research and Alternative Medicine, University of Wyoming) |
1 | Asakura, M., Kitakaze, M., Takashima, S., Liao, Y., Ishikura, F., et al. (2002) Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8, 35-40 DOI ScienceOn |
2 | Fischer, O. M., Hart, S., Gschwind, A., and Ullrich, A. (2003) EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31, 1203-1208 DOI |
3 | Kim, S. and Iwao, H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52, 11-34 |
4 | Marx, J. (2003). Heart disease. How to subdue a swelling heart. Science 300, 1492-1496 DOI ScienceOn |
5 | Montiel, M., de la Blanca, E. P., and Jimenez, E. (2005) Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 327, 971-978 DOI ScienceOn |
6 | Moriguchi, Y., Matsubara, H., Mori, Y., Murasawa, S., Masaki, H., et al. (1999) Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms. Circ. Res. 84, 1073-1084 DOI ScienceOn |
7 | Shah, B. H. and Catt, K. J. (2003) A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy. Trends Pharmacol. Sci. 24, 239-244 DOI ScienceOn |
8 | Shah, B. H. and Catt, K. J. (2004) Matrix metalloproteinasedependent EGF receptor activation in hypertension and left ventricular hypertrophy. Trends Endocrinol. Metab. 15, 241-243 DOI ScienceOn |
9 | Song, K., Shiota, N., Takai, S., Takashima, H., Iwasaki, H., et al. (1998) Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of highcholesterol fed Cynomolgus monkeys. Atherosclerosis 138, 171-182 DOI ScienceOn |
10 | Sreejayan, N., Lin, Y., and Hassid, A. (2002) NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism. Arterioscler. Thromb. Vasc. Biol. 22, 1086-1092 DOI ScienceOn |
11 | Yang, B. C., Phillips, M. I., Mohuczy, D., Meng, H., Shen, L., et al. (1998) Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 18, 1433-1439 DOI ScienceOn |
12 | Zhao, Y., Liu, J., Li, L., Liu, L., and Wu, L. (2005) Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul. Pept. 128, 43-50 DOI ScienceOn |
13 | Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., et al. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888 DOI ScienceOn |
14 | Andresen, B. T., Linnoila, J. J., Jackson, E. K., and Romero, G. G. (2003) Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension 41, 781-786 DOI ScienceOn |
15 | Pierce, K. L., Tohgo, A., Ahn, S., Field, M. E., Luttrell, L. M., et al. (2001) Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J. Biol. Chem. 276, 23155-23160 DOI ScienceOn |
16 | Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809 DOI ScienceOn |
17 | Rossi, F., Ferraresi, A., Romagni, P., Silvestroni, L., and Santiemma, V. (2002) Angiotensin II stimulates contraction and growth of testicular peritubular myoid cells in vitro. Endocrinology 143, 3096-3104 DOI ScienceOn |
18 | Schafer, B., Gschwind, A., and Ullrich, A. (2004) Multiple Gprotein- coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23, 991-999 DOI ScienceOn |
19 | Adachi, T., Cui, C. H., Kanda, A., Kayaba, H., Ohta, K., et al. (2004) Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells. Biochem. Biophys. Res. Commun. 320, 292-296 DOI ScienceOn |
20 | Leskinen, M. J., Kovanen, P. T., and Lindstedt, K. A. (2003) Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques. Biochem. Pharmacol. 66, 1493-1498 DOI ScienceOn |
21 | Yigzaw, Y., Poppleton, H. M., Sreejayan, N., Hassid, A., and Patel, T. B. (2003) Protein-tyrosine phosphatase-1B (PTP1B) mediates the anti-migratory actions of Sprouty. J. Biol. Chem. 278, 284-288 DOI ScienceOn |
22 | Du, M., Zhu, M. J., Means, W. J., Hess, B. W., and Ford, S. P. (2004). Effect of nutrient restriction on calpain and calpastatin content of skeletal muscle from cows and fetuses. J. Anim. Sci. 82, 2541-2547 |
23 | Kuhlmann, C. R., Schafer, M., Li, F., Sawamura, T., Tillmanns, H., et al. (2003) Modulation of endothelial Ca(2+)-activated K(+) channels by oxidized LDL and its contribution to endothelial proliferation. Cardiovasc. Res. 60, 626-634 DOI ScienceOn |
24 | Lupia, E., Pucci, A., Peasso, P., Merlo, M., Baron, P., et al. (2003) Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. Int. J. Mol. Med. 12, 327-334 |
25 | Bokemeyer, D., Schmitz, U., and Kramer, H. J. (2000) Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Kidney Int. 58, 549-558 |
26 | Cussac, D., Schaak, S., Denis, C., and Paris, H. (2002) alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation. J. Biol. Chem. 277, 19882-19888 DOI ScienceOn |
27 | Saito, S., Frank, G. D., Motley, E. D., Dempsey, P. J., Utsunomiya, H., et al. (2002) Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem. Biophys. Res. Commun. 294, 1023-1029 DOI ScienceOn |
28 | Hama, K., Ohnishi, H., Yasuda, H., Ueda, N., Mashima, H., et al. (2004) Angiotensin II stimulates DNA synthesis of rat pancreatic stellate cells by activating ERK through EGF receptor transactivation. Biochem. Biophys. Res. Commun. 315, 905-911 DOI ScienceOn |
29 | Braunwald, E. (1997) Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New. Engl. J. Med. 337, 1360-1369 DOI ScienceOn |
30 | Arrieta, O., Guevara, P., Escobar, E., Garcia-Navarrete, R., Pineda, B., et al. (2005) Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br. J. Cancer 92, 1247-1252 DOI ScienceOn |
31 | Liu, J., Liao, Z., Camden, J., Griffin, K. D., Garrad, R. C., et al. (2004) Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 279, 8212-8218 DOI ScienceOn |
32 | Ruiz-Ortega, M., Ruperez, M., Esteban, V., and Egido, J. (2003) Molecular mechanisms of angiotensin II-induced vascular injury. Curr. Hypertens. Rep. 5, 73-79 DOI ScienceOn |
33 | Fujiyama, S., Matsubara, H., Nozawa, Y., Maruyama, K., Mori, Y., et al. (2001) Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ. Res. 88, 2-29 DOI |
34 | Hao, L., Du, M., Lopez-Campistrous, A., and Fernandez-Patron, C. (2004) Agonist-induced activation of matrix metalloproteinase- 7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ. Res. 94, 68-76 DOI ScienceOn |
35 | Tamarat, R., Silvestre, J. S., Durie, M., and Levy, B. I. (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab. Invest. 82, 747-756 |
36 | Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., et al. (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3- integrin-targeted nanoparticles. Circulation 108, 2270-2274 DOI ScienceOn |
37 | Kalmes, A., Vesti, B. R., Daum, G., Abraham, J. A., and Clowes, A. W. (2000) Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 87, 92-98 DOI ScienceOn |
38 | Marra, D. E., Simoncini, T., and Liao, J. K. (2000) Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Circulation 102, 2124-2130 DOI ScienceOn |
39 | Eguchi, S., Frank, G. D., Mifune, M., and Inagami, T. (2003) Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling. Biochem. Soc. Trans. 31, 1198-1202 DOI |
40 | Sah, J. F., Balasubramanian, S., Eckert, R. L., and Rorke, E. A. (2004) Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279, 12755-12762 DOI ScienceOn |
41 | Touyz, R. M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., et al. (2003) Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can. J. Physiol. Pharmacol. 81, 159-167 DOI ScienceOn |
42 | Brown, C., Pan, X., and Hassid, A. (1999) Nitric oxide and Ctype atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Circ. Res. 84, 655-667 DOI ScienceOn |